Credit: Towfiqu Barbhuiya/Adobe Stock FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices
"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.
September 20, 2024 at 04:06 PM
6 minute read
Health Care
The original version of this story was published on National Law Journal
The Federal Trade Commission on Friday filed an administrative complaint against the three largest pharmacy benefit managers and their affiliated group purchasing organizations, alleging they have contributed to high insulin prices through anti-competitive practices.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All
AG in Texas Is Nation's First to Bring Gen AI Enforcement Action in Health Care
5 minute read
Latham & Watkins Secures Dismissal of Legal-Mal Suit Against Company, GC Who Failed to Advise Former Treasurer
4 minute read
Jury Hits York Neurosurgeon With Record $23.9M Verdict Over Botched Spine Operation
3 minute readTrending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
- 3Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5A RICO Surge Is Underway: Here's How the Allstate Push Might Play Out
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
